15 December 2020 - new issue

Shares in the York-based healthcare group have started trading on AIM today following a placing at 96p.  The medical device company has been leading the development of a Covid-19 antibody test and the funds raised in the placing will be used to scale up its manufacturing capabilities.  The company has raised £22m in the placing and the shares have opened at a useful premium to the placing price showing there is some demand for the stock.  Investors looking to invest in a company involved in Covid-19 should take a look as it . . .

This content is restricted to members only. We offer three packages from 1 month to a whole year of daily tips, market news and commentary, plus our monthly newsletters.
Registration is quick and simple HERE.

Already a member, log in HERE.